Medicare Enrolled
Dr. Harry Smith, MD
Hematology & Oncology · Port Arthur, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Smith
Dr. Harry Smith is a hematology & oncology specialist in Port Arthur, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Smith performed 631 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Smith received a total of $9,567 from 79 pharmaceutical and/or device companies across 482 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Smith is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 631 Medicare services
$9,567 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗631
Medicare services
Bottom 37% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
441 | $67 | $377 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
107 | $102 | $526 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $44 | $265 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $50 | $325 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $132 | $578 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $89 | $487 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,567
Total received (2018-2024)
Avg $1,367/year across 7 years
Top 32% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
482
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,798
2023
$1,687
2022
$1,636
2021
$337
2020
$528
2019
$1,948
2018
$1,632
Payments by company (2024)
PFIZER INC.
$184
Janssen Biotech, Inc.
$146
Astellas Pharma US Inc
$124
Daiichi Sankyo Inc.
$93
Celgene Corporation
$88
GlaxoSmithKline, LLC.
$70
Incyte Corporation
$65
PUMA BIOTECHNOLOGY, INC.
$62
SOBI, INC
$59
GENZYME CORPORATION
$56
Merck Sharp & Dohme LLC
$56
Eisai Inc.
$55
Novartis Pharmaceuticals Corporation
$54
Rigel Pharmaceuticals, Inc.
$51
Janssen Pharmaceuticals, Inc
$46
Takeda Pharmaceuticals U.S.A., Inc.
$44
E.R. Squibb & Sons, L.L.C.
$42
ABBVIE INC.
$40
Agios Pharmaceuticals, Inc.
$40
Stemline Therapeutics Inc.
$37
Pharmacosmos Therapeutics Inc.
$31
Alexion Pharmaceuticals, Inc.
$30
Immunocore Limited
$27
TerSera Therapeutics LLC
$25
Boston Scientific Corporation
$25
Gilead Sciences, Inc.
$22
Karyopharm Therapeutics Inc.
$22
Exelixis Inc.
$22
EMD Serono, Inc.
$21
Genentech USA, Inc.
$20
Lilly USA, LLC
$19
BeiGene USA, Inc.
$19
Genmab U.S., Inc.
$19
Tolmar, Inc.
$18
Pharming Healthcare, Inc.
$18
Tactile Systems Technology Inc
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Mirati Therapeutics, Inc.
$16
Top 3 companies account for 25.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$649
PFIZER INC.
$569
Genentech USA, Inc.
$528
E.R. Squibb & Sons, L.L.C.
$493
Celgene Corporation
$433
Seagen Inc.
$398
Astellas Pharma US Inc
$380
Boehringer Ingelheim Pharmaceuticals, Inc.
$331
GENZYME CORPORATION
$329
Novartis Pharmaceuticals Corporation
$314
Merck Sharp & Dohme Corporation
$293
Incyte Corporation
$275
GlaxoSmithKline, LLC.
$264
Daiichi Sankyo Inc.
$234
Lilly USA, LLC
$209
AstraZeneca Pharmaceuticals LP
$198
Eisai Inc.
$197
Rigel Pharmaceuticals, Inc.
$185
Amgen Inc.
$173
Takeda Pharmaceuticals U.S.A., Inc.
$170
Merck Sharp & Dohme LLC
$158
Exelixis Inc.
$149
Clovis Oncology, Inc.
$146
MEDIVATION FIELD SOLUTIONS LLC
$116
Sun Pharmaceutical Industries Inc.
$110
BeiGene USA, Inc.
$106
PUMA BIOTECHNOLOGY, INC.
$101
Puma Biotechnology, Inc.
$94
Alexion Pharmaceuticals, Inc.
$92
AVEO Pharmaceuticals, Inc.
$91
SOBI, INC
$86
Janssen Pharmaceuticals, Inc
$75
ABBVIE INC.
$73
TerSera Therapeutics LLC
$65
Janssen Products, LP
$65
Pharmacyclics LLC, An AbbVie Company
$62
EMD Serono, Inc.
$61
Gilead Sciences, Inc.
$59
Stemline Therapeutics Inc.
$57
Regeneron Healthcare Solutions, Inc.
$57
Karyopharm Therapeutics Inc.
$57
Pharmacyclics LLC, an AbbVie Company
$56
Deciphera Pharmaceuticals Inc.
$47
TESARO, Inc.
$47
Mylan Institutional Inc.
$43
Dendreon Pharmaceuticals LLC
$40
Agios Pharmaceuticals, Inc.
$40
Blueprint Medicines Corporation
$39
Genmab U.S., Inc.
$39
Alnylam Pharmaceuticals Inc.
$37
EISAI INC.
$37
JAZZ PHARMACEUTICALS INC.
$37
Taiho Oncology, Inc.
$33
Mirati Therapeutics, Inc.
$32
Pharmacosmos Therapeutics Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$30
Seattle Genetics, Inc.
$28
MACROGENICS, INC.
$28
Immunocore Limited
$27
Jazz Pharmaceuticals Inc.
$27
ARRAY BIOPHARMA INC
$27
Boston Scientific Corporation
$25
PharmaEssentia USA Corporation
$24
Apellis Pharmaceuticals, Inc.
$24
CTI BioPharma Corp.
$23
Kyowa Kirin, Inc.
$20
TAIHO ONCOLOGY, INC.
$20
AbbVie, Inc.
$19
Array BioPharma Inc.
$19
Ipsen Biopharmaceuticals, Inc
$19
MorphoSys, US Inc.
$19
Tolmar, Inc.
$18
Pharming Healthcare, Inc.
$18
Tactile Systems Technology Inc
$17
Octapharma USA, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Lantheus Medical Imaging, Inc.
$16
AMAG Pharmaceuticals, Inc.
$15
Dova Pharmaceuticals
$14
Top 3 companies account for 18.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Avastin · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Flexitouch Plus · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MARGENZA · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OJJAARA · OPDIVO · Ogivri · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · Quadramet · REBLOZYL · RUCONEST · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SPRYCEL · SYNAGIS · Somatuline Depot · Stivarga · TAGRISSO · TECENTRIQ · TUKYSA · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Tivdak · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vonjo · WILATE · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Smith is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Smith experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Smith performed 441 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $9,567 from 79 companies across 482 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smith's costs compare to other hematology & oncology specialists in Port Arthur?
Dr. Smith's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Port Arthur
Browse hematology & oncology specialists in Port Arthur ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology